Study Suggests ApoB Test Outperforms LDL for Cardiovascular Risk Assessment

Northwestern Medicine researchers have published new findings in JAMA, indicating that measuring apolipoprotein B (apoB) is a more effective blood test than traditional LDL cholesterol for identifying individuals at high risk of heart attacks and strokes. The study suggests that adopting apoB testing could prevent more cardiovascular events and be a cost-effective addition to the U.S. healthcare system. This research could lead to more precise preventative treatments for heart disease.